(ALHC) Alignment Healthcare - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US01625V1044

ALHC: Medicare, Advantage, Plans, Health, Care, Services

Alignment Healthcare LLC (NASDAQ: ALHC) is a tech-driven Medicare Advantage insurer that has carved out a niche serving seniors in the United States. Founded in 2013 and headquartered in Orange, California, the company has built a platform that relies heavily on data analytics and personalized care coordination to deliver tailored health plans for its members. Its consumer-centric approach focuses on addressing the diverse needs of seniors, a demographic that often requires more complex and coordinated medical care.

The companys value proposition lies in its ability to leverage technology to improve health outcomes and reduce costs. By integrating advanced analytics, Alignment Healthcare can identify high-risk patients earlier and intervene with preventive measures. This proactive approach not only enhances the quality of care but also helps in managing medical expenses, which is critical in the Medicare Advantage space where margins are thin. The companys platform also includes tools for care management, patient engagement, and network optimization, all of which contribute to a more efficient healthcare delivery model.

From a financial perspective, Alignment Healthcare operates in a growing market. The Medicare Advantage program has seen steady enrollment increases, driven by the aging U.S. population and the attractiveness of MA plans over traditional Medicare. The companys market capitalization stands at $2.658 billion, reflecting investor confidence in its growth prospects. While the stock currently trades at a price-to-sales ratio of 1.08, the companys focus on operational efficiency and expansion into new markets could drive future valuation changes. Notably, the companys price-to-book ratio of 23.21 indicates a premium valuation relative to its book value, which may be attributed to its technology-driven business model and growth trajectory.

Alignment Healthcares strategy revolves around scaling its Medicare Advantage plans while maintaining its focus on senior care. The company has demonstrated an ability to expand into new geographic markets while maintaining its core competencies in care coordination and cost management. For investors, the key will be monitoring how effectively the company can balance growth with profitability in a highly competitive and regulated industry. Its ability to innovate and adapt to changing regulatory and market conditions will be critical to its long-term success.

Ticker Symbol: ALHC Exchange: NASDAQ Type: common stock Country Origin: United States GICS Sub Industry: Health Care Services Market Cap or AUM: 2658.82M USD P/E: 0.00 P/E Forward: 0.00 P/B: 23.21 P/S: 1.08

Web URL: https://www.alignmenthealth.com

Additional Sources for ALHC Stock

ALHC Stock Overview

Market Cap in USD 2,925m
Sector Healthcare
Industry Healthcare Plans
GiC Sub-Industry Health Care Services
IPO / Inception 2021-03-26

ALHC Stock Ratings

Growth 5y 2.15%
Fundamental -7.08%
Dividend 0.0%
Rel. Strength Industry 225
Analysts 4.23/5
Fair Price Momentum 17.08 USD
Fair Price DCF 4.00 USD

ALHC Dividends

No Dividends Paid

ALHC Growth Ratios

Growth Correlation 3m 75.5%
Growth Correlation 12m 95.2%
Growth Correlation 5y -51.3%
CAGR 5y -2.29%
CAGR/Max DD 5y -0.03
Sharpe Ratio 12m 1.32
Alpha 218.70
Beta 0.72
Volatility 61.17%
Current Volume 3851k
Average Volume 20d 2551.9k
What is the price of ALHC stocks?
As of March 15, 2025, the stock is trading at USD 15.79 with a total of 3,851,034 shares traded.
Over the past week, the price has changed by +6.04%, over one month by +15.42%, over three months by +40.86% and over the past year by +227.59%.
Is Alignment Healthcare a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Alignment Healthcare is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -7.08 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ALHC as of March 2025 is 17.08. This means that ALHC is currently overvalued and has a potential downside of 8.17%.
Is ALHC a buy, sell or hold?
Alignment Healthcare has received a consensus analysts rating of 4.23. Therefor, it is recommend to buy ALHC.
  • Strong Buy: 8
  • Buy: 1
  • Hold: 3
  • Sell: 1
  • Strong Sell: 0
What are the forecast for ALHC stock price target?
According to ValueRays Forecast Model, ALHC Alignment Healthcare will be worth about 18.8 in March 2026. The stock is currently trading at 15.79. This means that the stock has a potential upside of +19.06%.
Issuer Forecast Upside
Wallstreet Target Price 17.1 8%
Analysts Target Price 13.3 -16%
ValueRay Target Price 18.8 19.1%